Research Correspondence

DOI: 10.4244/EIJ-D-24-01048

Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation

Yohanna John Zendo1, MD; Santiago Ordoñez1, MD; Michael W.A. Chu1, MD; Matthew Valdis1, MD; Siobhan Molloy1, MN-NP; Mosa Abbadi1, MD; Patrick Teefy1, MD; Pantelis Diamantouros1, MD; Rodrigo Bagur1, MD, PhD

Early discharge (ED) and next-day discharge (NDD) pathways following transfemoral (TF) transcatheter aortic valve implantation (TAVI) have been gaining acceptance among Heart Teams123. We recently demonstrated the safety and feasibility of NDD following TAVI with three different types of commercially available transcatheter heart valves3. However, there is a lack of data on ED and NDD in patients undergoing TAVI using alternative access (A-TAVI). Therefore, this research assessed the safety of an ED/NDD pathway in patients who underwent A-TAVI.

Data from consecutive, all-comers patients who underwent elective A-TAVI between July 2018 and November 2024 were prospectively collected in a dedicated database. Patients followed a fast-track anaesthesia pathway consisting of extubation in the hybrid operating room, 1-hour recovery in the post-anaesthesia care unit, and transfer to the inpatient ward, similar to TF-TAVI under conscious sedation23. Mobilisation was promptly encouraged within four hours following the completion of the procedure, and a transthoracic echocardiogram was performed the following morning. Patients had an electrocardiogram (ECG) shortly after TAVI and again the following day. To qualify for the NDD pathway,...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Receive our newsletter


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00056 Dec 16, 2024
Is next-day discharge after uncomplicated transcatheter aortic valve implantation the new standard of care?
Costa G and Sammartino S
free

Original Research

10.4244/EIJ-D-24-00514 Dec 16, 2024
Readmissions after next-day discharge following transcatheter aortic valve implantation
Bagur R et al

10.4244/EIJV13I8A135 Oct 20, 2017
Day case TAVI: is this a reality?
Jabbour R et al
free

10.4244/EIJV15I2A25 Jun 20, 2019
Discharge after TAVI: it can be fast
van Wiechen M et al
free

EXPERT REVIEW

10.4244/EIJ-D-18-00552 Sep 7, 2018
Current state of alternative access for transcatheter aortic valve implantation
Lanz J et al
free
Trending articles
310.43

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.35

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved